US Bancorp’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.6M Buy
892,375
+1,080
+0.1% +$22.5K 0.02% 321
2026
Q1
$18.7M Buy
891,295
+42,472
+5% +$897K 0.02% 312
2025
Q4
$18M Buy
848,823
+47,742
+6% +$1.01M 0.02% 340
2025
Q3
$17M Sell
801,081
-8,084
-1% -$170K 0.02% 352
2025
Q2
$17M Buy
809,165
+109,147
+16% +$2.25M 0.02% 346
2025
Q1
$14.5M Buy
700,018
+76,847
+12% +$1.58M 0.02% 372
2024
Q4
$12.7M Sell
623,171
-15,750
-2% -$326K 0.02% 392
2024
Q3
$13.6M Buy
638,921
+293,163
+85% +$6.11M 0.02% 382
2024
Q2
$7.02M Buy
345,758
+159,925
+86% +$3.23M 0.01% 496
2024
Q1
$3.81M Buy
+185,833
New +$3.8M 0.01% 645

Other funds holding IBDW

US Bancorp's IBDW Position: Q2 2026 in Review

US Bancorp increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 0.12% in Q2 2026, buying an estimated $22.5K and bringing the position to 892,375 shares worth $18.6M. The position accounts for 0.02% of the portfolio, ranked #321.

US Bancorp first reported a position in IBDW in Q1 2024 and has held it in 10 quarters since. The position peaked at $18.7M in Q1 2026. 290 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

  • US Bancorp held 892,375 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $18.6M as of Q2 2026.
  • US Bancorp bought 1,080 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $22.5K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.02% of US Bancorp's portfolio in Q2 2026, its #321 holding.
  • US Bancorp first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • US Bancorp's iShares iBonds Dec 2031 Term Corporate ETF position peaked at $18.7M in Q1 2026.
  • 290 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.